France· FR:65463715
DUGRESSA 1 mg/mL + 5 mg/mL, collyre en solution
A medicinal product containing phosphate sodique de dexaméthasone + lévofloxacine hémihydratée, registered in France by SANTEN OY.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PHOSPHATE SODIQUE DE DEXAMÉTHASONE + LÉVOFLOXACINE HÉMIHYDRATÉE
- Manufacturer
- SANTEN OY
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009302105361 flacon(s) polyéthylène basse densité (PEBD) avec compte-gouttes de 5 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Phosphate sodique de dexaméthasone + lévofloxacine hémihydratée in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandDucressaDelfarma Sp. z o.o.
- SpainDUCRESSA 1 MG/ML + 5 MG/ML COLIRIO EN SOLUCIONSanten Oy
- IrelandDucressa 1 mg/ml + 5 mg/ml, eye drops, solutionSanten OY
- IcelandDucressaSanten Oy*
- NetherlandsDucressa 1 mg/ml / 5 mg/ml, oogdruppels, oplossingSanten Oy
- NorwayDucressaSanten Oy (1)
- GermanyLevendexNtc Srl
- SwedenDucressa 1 mg/ml + 5 mg/ml Ögondroppar, lösningSanten Oy
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Belgium · Ducressa
- Bulgaria · Ducressa
- Germany · Levendex
- Estonia · Ducressa
- Greece · Ducressa
- Croatia · Ducressa
- Ireland · Ducressa
- Italy · Ducressa, Leviosa
- Lithuania · Ducressa
- Netherlands · Ducressa
- Norway · Ducressa
- Romania · Ducressa Md
- Sweden · Ducressa
- Slovenia · Ducressa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1fa914d0-52fe-4ec5-9931-9b13664c6a18 GET /v1/drugs/1fa914d0-52fe-4ec5-9931-9b13664c6a18?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65463715",
"date_amm": "2020-07-07",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "PHOSPHATE SODIQUE DE DEXAMÉTHASONE + LÉVOFLOXACINE HÉMIHYDRATÉE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about phosphate sodique de dexaméthasone + lévofloxacine hémihydratée.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.